Medicine
Lidocaine 2000 mg/250 mL injection
Lidocaine 2000 mg/250 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
It is recommended the product be stored at room temperature (25°C), brief…
Key facts
- Active ingredient (INN)
- Lidocaine
- Brand
- Sold under the generic name
- Strength
- 2000 mg/250 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 bags of 250 mL, 250 mL
- Manufacturers
- Baxter HealthcareHealthFirst
- Origin register
- US FDA, United States
- Storage
- It is recommended the product be stored at room temperature (25°C), brief exposure up to 40°C does not adversely affect the product.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BB01 Lidocaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 April 1981
- Identifiers
- RxCUI 1737723, 1737742, 1737744DailyMed set ID f21512ea-c7c3-4766-b976-b2c0b5616bf0, 1bf999b5-e290-dcbd-e063-6294a90a2babNDC 0338-0411, 51662-1657Application NDA018461
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 bag in 1 carton / 250 mL in 1 bag | 0338-0411-02 | Baxter Healthcare | 22 April 1981 |
| 250 mL in 1 bag | 51662-1657-1 | HealthFirst | 22 April 1981 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 November 1948 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Lidocaine
Clinical summary
Lidocaine is an amide local anesthetic. It is available as injection, ointment and patches for infiltration, perineural and topical use. MedsAcross supplies Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LidocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xylocaine prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Lidocaine 2000 mg/250 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.